About Alluxi
Alluxi sells state of the art tumor genome mutation profiling. This is a mutation detection analysis in cancer cells DNA also called multiplexed molecular - Breast Cancer Profile: Resolve HER2 Equivocal Status, PIK3CA, Molecular Sub-Typing, CGH ~ - Melanoma Profile: Cobas FDA-approved BRAF mutation testing. If negative, confirms and reflex to Extended Mass Spectrometry Genotyping ~ - Lung Cancer Profile: Cobas FDA-approved EGFR mutation testing, Extended Mass Spectrometry Genotyping ~ - Colon Cancer Profile: KRAS/BRAF: Extended Mass Spectrometry Genotyping ~ - Ovarian Cancer Profile: Risk Stratification by CGH ~ - Thyroid Panel: BRAF/NRAS/RET: Extended Mass Spectrometry Genotyping ~ - Brain Tumor Profile:GBM Sub-Typing by CGH, Oligodendroglioma (1p/19q), IDH1/IDH2, MGMT by methylation, Edpendyoma Profile by CGH ~ - Hematology Profile: MDS or CLL by CGH Specialties Oncogenomics analysis
Alluxi Job Openings
Create job profile to receive interview calls for your dream job
Create Job Alert Kick Start! your career with best matching jobs
Location
X